{
  "content": "Antiretrovirals. The co-administration of amiodarone with antiretroviral (ARV) ther-apy is complex due to shared involvement in the CYP450 enzyme system. ARVs can act as substrates, inhibitors, or inducers, affecting glucuronidation and P-gp transport [ 58 ]. Amiodarone’s inhibition of CYP3A4 and P-gp may lead to ARV accumulation [ 59 ]. Signif-icant interactions have been observed with protease inhibitors (PIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs), influencing serum concentrations. NNRTIs like efavirenz and rilpivirine may cause QT prolongation and cardiotoxicity. ARVs that increase amiodarone serum levels include atazanavir, darunavir, fosamprenavir, indinavir, lopinavir, nelfinavir, saquinavir, and elvitegravir",
  "source": "https://pdfs.semanticscholar.org/eda9/09ebe34c58658072d9d3a1e6db13d581c6cd.pdf?skipShowableCheck=true",
  "chunk_id": "f8f22a80-2a88-4f24-9863-b8362aec051f",
  "similarity_score": 0.27955150604248047,
  "query": "amiodarone drug interactions contraindications beta-blockers digoxin warfarin CYP450 metabolism",
  "rank": 40,
  "title": "Amiodarone Therapy: Updated Practical Insights",
  "authors": "Sorodoc, V., Indrei, L., Dobroghii, C., Asaftei, A., Ceasovschih, A., Constantin, M., Lionte, C., Morărasu, B. C., Diaconu, A.-D., Sorodoc, L.",
  "year": "2024",
  "journal": "Journal of Clinical Medicine",
  "reference": "Sorodoc, V., Indrei, L., Dobroghii, C., Asaftei, A., Ceasovschih, A., Constantin, M., Lionte, C., Morărasu, B. C., Diaconu, A.-D., & Sorodoc, L. (2024). Amiodarone therapy: Updated practical insights. Journal of Clinical Medicine, 13(20), 6094. https://doi.org/10.3390/jcm13206094",
  "doi": "10.3390/jcm13206094",
  "chunk_index": 58,
  "total_chunks": 209,
  "retrieved_at": "2025-07-24T22:33:49.726031"
}